229 related articles for article (PubMed ID: 38051146)
21. Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis.
Paller AS; Stein Gold L; Soung J; Tallman AM; Rubenstein DS; Gooderham M
J Am Acad Dermatol; 2021 Mar; 84(3):632-638. PubMed ID: 32502588
[TBL] [Abstract][Full Text] [Related]
22. A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.
Peppers J; Paller AS; Maeda-Chubachi T; Wu S; Robbins K; Gallagher K; Kraus JE
J Am Acad Dermatol; 2019 Jan; 80(1):89-98.e3. PubMed ID: 30554600
[TBL] [Abstract][Full Text] [Related]
23. Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials.
Jett J; McLaughlin M; Wilson T; Somerville M; DellaMaestra W; Rubenstein D; Piscitelli S
J Drugs Dermatol; 2022 Oct; 21(10):1084-1090. PubMed ID: 36219046
[TBL] [Abstract][Full Text] [Related]
24. Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis.
Eichenfield LF; Silverberg JI; Hebert AA; Chovatiya R; Brown PM; McHale KA; Rubenstein DS; Tallman AM
J Drugs Dermatol; 2024 Feb; 23(2):23-28. PubMed ID: 38306128
[TBL] [Abstract][Full Text] [Related]
25. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
[TBL] [Abstract][Full Text] [Related]
26. 1% Tapinarof cream for the treatment of psoriasis: a network meta-analysis of randomized placebo- and calcipotriol- controlled trials.
Yan J; Chen S; Shi J
Arch Dermatol Res; 2023 Dec; 316(1):31. PubMed ID: 38060043
[TBL] [Abstract][Full Text] [Related]
27. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
28. First Use of Combination Oral Deucravacitinib With Tapinarof Cream for Treatment of Severe Plaque Psoriasis.
Abdin R; Kircik L; Issa NT
J Drugs Dermatol; 2024 Mar; 23(3):192-194. PubMed ID: 38443116
[TBL] [Abstract][Full Text] [Related]
29. Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research.
Bissonnette R; Saint-Cyr Proulx E; Jack C; Maari C
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1168-1174. PubMed ID: 36708084
[TBL] [Abstract][Full Text] [Related]
30. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.
Silverberg JI; Eichenfield LF; Hebert AA; Simpson EL; Stein Gold L; Bissonnette R; Papp KA; Browning J; Kwong P; Korman NJ; Brown PM; Rubenstein DS; Piscitelli SC; Somerville MC; Tallman AM; Kircik L
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38777187
[TBL] [Abstract][Full Text] [Related]
31. Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies.
Lie E; Choi M; Wang SP; Eichenfield LF
Paediatr Drugs; 2024 Jan; 26(1):9-18. PubMed ID: 37847480
[TBL] [Abstract][Full Text] [Related]
32. Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Silverberg JI; Boguniewicz M; Quintana FJ; Clark RA; Gross L; Hirano I; Tallman AM; Brown PM; Fredericks D; Rubenstein DS; McHale KA
J Allergy Clin Immunol; 2023 Dec; ():. PubMed ID: 38154665
[TBL] [Abstract][Full Text] [Related]
33. Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study.
Bissonnette R; Vasist LS; Bullman JN; Collingwood T; Chen G; Maeda-Chubachi T
Clin Pharmacol Drug Dev; 2018 Jun; 7(5):524-531. PubMed ID: 29389078
[TBL] [Abstract][Full Text] [Related]
34. A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.
Pixley JN; Schaetzle T; Feldman SR
Ann Pharmacother; 2023 Aug; 57(8):966-969. PubMed ID: 36420929
[TBL] [Abstract][Full Text] [Related]
35. New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 2: Tapinarof.
DiRuggiero M; Mancuso-Stewart E; DiRuggiero D; Zirwas M
Skinmed; 2023; 21(3):177-181. PubMed ID: 37634099
[TBL] [Abstract][Full Text] [Related]
36. Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.
Smith SH; Jayawickreme C; Rickard DJ; Nicodeme E; Bui T; Simmons C; Coquery CM; Neil J; Pryor WM; Mayhew D; Rajpal DK; Creech K; Furst S; Lee J; Wu D; Rastinejad F; Willson TM; Viviani F; Morris DC; Moore JT; Cote-Sierra J
J Invest Dermatol; 2017 Oct; 137(10):2110-2119. PubMed ID: 28595996
[TBL] [Abstract][Full Text] [Related]
37. Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
Papp KA; Gooderham M; Droege M; Merritt C; Osborne DW; Berk DR; Thurston AW; Smith VH; Welgus H
J Drugs Dermatol; 2020 Aug; 19(8):734-740. PubMed ID: 32845114
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies.
Thurston AW; Osborne DW; Snyder S; Higham RC; Burnett P; Berk DR
Am J Clin Dermatol; 2023 Mar; 24(2):315-324. PubMed ID: 36422852
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]